Related Experiment Videos
Structure-activity relationships of podophyllin congeners that inhibit topoisomerase II
Abstract:
Various analogs of etoposide have been studied and compared in different tests in order to identify which tests best correlate with antitumor activity. These tests included DNA breakage assays using standard alkaline elution procedures as a means of studying topoisomerase II inhibition in intact cells, cytotoxicity studies in naturally sensitive and resistant human carcinoma cell lines, in vitro assays of the effect of the different congeners on topoisomerase II activity, and a preliminary evaluation of the ability of etoposide and teniposide to induce resistance. As in previous studies, a direct correlation was seen between double strand DNA breakage and cytotoxicity but not between single strand DNA breakage and cytotoxicity. Analogs with blocked 4'-hydroxyl groups were poor antitumor agents but were still capable of inhibiting topoisomerase II as evidenced by the production of DNA breaks. However, this DNA breakage was qualitatively different from that produced by VP16. None of the analogs were able to overcome either naive or acquired drug resistance. The dihydroxy analog of VP16, a possible bioactivated analog, was much less potent and possibly less stable than VP16. A model is proposed for the inhibition of topoisomerase II by demethylepipodophyllotoxins that may explain the relationship between double strand DNA breakage and cytotoxicity.
Insights
Researchers compared etoposide analogs to find tests correlating with antitumor activity. Double-strand DNA breaks, not single-strand, correlated with cytotoxicity, but analogs showed limited efficacy against drug resistance.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Etoposide (VP16) is a crucial topoisomerase II inhibitor used in cancer therapy.
- Understanding structure-activity relationships is key to developing more effective anticancer agents.
- Previous studies suggest DNA damage is central to etoposide's mechanism of action.
Purpose of the Study:
- To identify assays that best correlate with the antitumor activity of etoposide analogs.
- To investigate the relationship between DNA breakage, topoisomerase II inhibition, and cytotoxicity.
- To evaluate the potential of etoposide analogs in overcoming drug resistance.
Main Methods:
- DNA breakage assays (alkaline elution) to assess topoisomerase II inhibition in intact cells.
- Cytotoxicity studies in human carcinoma cell lines (sensitive and resistant).
- In vitro assays measuring topoisomerase II activity and drug resistance induction.
Main Results:
- Direct correlation observed between double-strand DNA breaks and cytotoxicity.
- Single-strand DNA breaks did not correlate with cytotoxicity.
- Analogs with blocked 4'-hydroxyl groups showed reduced antitumor activity despite inducing DNA breaks.
- No analogs effectively overcame naive or acquired drug resistance.
- A dihydroxy analog of VP16 was less potent and stable than VP16.
Conclusions:
- Double-strand DNA breakage is a critical indicator of etoposide analog antitumor efficacy.
- Structural modifications, like blocking the 4'-hydroxyl group, can impair activity without fully abolishing topoisomerase II inhibition.
- Current etoposide analogs are ineffective against both inherent and acquired resistance mechanisms.
- A model for topoisomerase II inhibition by demethylepipodophyllotoxins is proposed to explain observed correlations.